Search FDA's QSR Interpretation:     Advanced Search

 

 

 

 

 

 

 

820.100 Corrective and preventive action.

 

(a) Each manufacturer shall establish and maintain procedures for implementing corrective and preventive action. The procedures shall include requirements for:

(1) Analyzing processes, work operations, concessions, quality audit reports, quality records, service records, complaints, returned product, and other sources of quality data to identify existing and potential causes of nonconforming product, or other quality problems. Appropriate statistical methodology shall be employed where necessary to detect recurring quality problems;

(2) Investigating the cause of nonconformities relating to product, processes, and the quality system;

(3) Identifying the action(s) needed to correct and prevent recurrence of nonconforming product and other quality problems;

(4) Verifying or validating the corrective and preventive action to ensure that such action is effective and does not adversely affect the finished device;

(5) Implementing and recording changes in methods and procedures needed to correct and prevent identified quality problems;

(6) Ensuring that information related to quality problems or nonconforming product is disseminated to those directly responsible for assuring the quality of such product or the prevention of such problems; and

(7) Submitting relevant information on identified quality problems, as well as corrective and preventive actions, for management review.

(b) All activities required under this section, and their results, shall be documented.

Interpretation:

This section requires an analysis of problem data, returned product, and an investigation of non-conforming product. Also 820.198 requires an investigation of complaints that allege a device does not meet specifications. Section 820.100 refers to analysis of processes, work operations, concessions, quality audit reports, quality records, service records, complaints, returned product, and other sources of quality data to identify existing and potential causes of nonconforming or other quality problems. Section 820.198 also involves reviewing and evaluating complaints to determine whether or not an investigation is necessary. All these activities and their results shall be documented.

Some devices have a specified requirement for servicing. If this is the case, the manufacturer shall establish and maintain instructions and procedures for performing and verifying this servicing (820.200). The servicing reports shall also be analyzed using 820.100, Corrective and Preventive Action; if the servicing involves a death or serious injury, the service report is considered to be a complaint per section 820.198, Complaint Files, and is reported to FDA per parts 803 and 804, Medical Device Reporting.

The significance of the device and any hazard the defective device presents should be taken into consideration when determining compliance with corrective and preventive action requirements. Analysis shall be taken to the level necessary to determine the actual failure mechanism, e.g., defective component, incorrect raw material, erosion, composition, etc. The cause of failure is obvious in some cases and a formal investigation may not be needed. A record of the investigation, follow up, and conclusions shall be made in accordance with section 820.100.

When a systematic failure has been diagnosed, manufacturers need not analyze every device with the same diagnosed symptoms. However, enough devices should be analyzed to clearly establish symptoms before any assumptions are made about the cause of failure or about corrective actions. When an investigation results in identification of a deficiency, such as a failed component or a design flaw, and this deficiency may exist in other product lines, the investigation will not be effective unless it extends to determining the effect on other product lines.

If the failure is design related, the design shall be corrected per the design control requirements in 820.30 in order for the devices to meet company quality claims and not be adulterated under the FD&C Act section 501(c). When a failure is determined to be related to documentation, assembly, processing, labeling, testing, packaging, or other manufacturing operations, the manufacturing deficiency shall be identified, corrected, and documented.

 

 *** for more extensive look ---- Download our 328 page guide to Interpretation of FDA's QSR with QSIT Reference!

 

 

 

 

Reference: www.FDA.gov

 

The information provided here is for "public consumption" and is open to interpretation. MedicalDeviceSchool.com is not responsible for the content or the accuracy of the information. For all official interpretation and accuracy we ask that you consult the FDA's website directly and that you consult with your legal and regulatory experts on all matters of interpretation.